The syrup for children Dafalgan recalled by its …

The producer of Dafalgan syrup for children against headaches, toothaches and joint pain is recalling the batches with an expiration date until the end of October 2018 inclusive. In question, a possible contamination by synthetic particles.

The American pharmaceutical company Bristol-Myers Squibb has indicated that “to date, no contamination of the product has been observed and no claims or reports of adverse effects in connection with this recall have been recorded”, according to the Swissmedic newsletter published on Monday.

The 30 mg / ml solution of Dafalgan syrup for children is recalled “for purely preventive purposes”. Lot R5163 is not affected. Persons in possession of another batch can return it to the supplier. The returned product will be reimbursed by Bristol-Myers Squibb.